Fusion Pharmaceuticals Inc
(FUSN)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2021 | 06-2021 | 03-2021 | 12-2020 | 09-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -63,811 | -44,382 | -17,529 | -78,333 | -64,948 |
| Depreciation Amortization | 450 | 265 | 111 | 482 | 373 |
| Income taxes - deferred | -670 | -413 | N/A | -576 | -28 |
| Accounts receivable | -300 | -121 | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 413 | -2,687 | -2,346 | 2,558 | 150 |
| Other Working Capital | -12,702 | -5,157 | -5,586 | 5,736 | -3,255 |
| Other Operating Activity | 17,207 | 14,592 | 4,754 | 40,366 | 41,023 |
| Operating Cash Flow | $-59,413 | $-37,903 | $-20,596 | $-29,767 | $-26,685 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -953 | -793 | -584 | -1,123 | -1,063 |
| Purchase Of Investment | -157,424 | -132,137 | -66,074 | -219,030 | -54,286 |
| Sale Of Investment | 165,255 | 107,591 | 37,660 | 9,700 | N/A |
| Investing Cash Flow | $6,878 | $-25,339 | $-28,998 | $-210,453 | $-55,349 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 613 | 340 | 130 | 197,681 | 197,625 |
| Other Financing Activity | -216 | 0 | 0 | 67,826 | 67,826 |
| Financing Cash Flow | $397 | $340 | $130 | $265,507 | $265,451 |
| Exchange Rate Effect | N/A | N/A | 17 | N/A | N/A |
| Beginning Cash Position | 92,408 | 92,408 | 92,408 | 67,121 | 67,121 |
| End Cash Position | 40,270 | 29,506 | 42,961 | 92,408 | 250,538 |
| Net Cash Flow | $-52,138 | $-62,902 | $-49,447 | $25,287 | $183,417 |
| Free Cash Flow | |||||
| Operating Cash Flow | -59,413 | -37,903 | -20,596 | -29,767 | -26,685 |
| Capital Expenditure | -953 | -793 | -584 | -1,123 | -1,063 |
| Free Cash Flow | -60,366 | -38,696 | -21,180 | -30,890 | -27,748 |